Previous 10 | Next 10 |
home / stock / mdp:cc / mdp:cc news
Expanded indication includes patients under 12 years of age, based on Phase 3/4 data demonstrating safety and efficacy in previously treated patients in this age group Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 26, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) to...
Fiscal Q3 2024 revenue of $25.2 million, Operating income of $1.6 million, and Adjusted EBITDA* of $3.2 million Management to host conference call at 8:00 AM Eastern time on Thursday, February 8, 2024 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 7, 2024) - Medexus Pharm...
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 30, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February 8, 2024 to discuss Medexus's results for its third fiscal quarter ended December 31, 20...
Topical terbinafine has been widely used in other markets to treat fungal nail infections If and when approved, the product will enter the topical fungicides market that is estimated to be C$88 million on an annual basis* Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 8, 2...
Whitemud Resources Inc. (WMK:CA) is expected to report for quarter end 2023-09-30 Avanti Helium Corp. (AVN:CA) is expected to report for quarter end 2023-09-30 Advantex Marketing International Inc (ADX:CNX) is expected to report for quarter end 2023-09-30 Royal Helium Ltd. (RHC:CA) is...
Nubian Resources Ltd. (NBR:CA) is expected to report for quarter end 2023-10-31 EQB Inc. (EQB:CA) is expected to report $2.97 for Q3 2023 Magna Gold Corp. (MGR.H:CA) is expected to report for quarter end 2023-09-30 Royal Helium Ltd. (RHC:CA) is expected to report for quarter end 2023-...
Allkem Limited Ordinary Shares (AKE:CA) is expected to report $0.05 for Q1 2024 Wall Financial Corporation (WFC:CA) is expected to report for Q2 2024 Avanti Helium Corp. (AVN:CA) is expected to report for quarter end 2023-09-30 Transcontinental Inc. Class B Multiple Voting Shares (TCL...
Mistango River Resources Inc (MIS:CNX) is expected to report for quarter end 2023-09-30 Forza Petroleum Limited (FORZ:CA) is expected to report for Q1 2024 Whitemud Resources Inc. (WMK:CA) is expected to report for quarter end 2023-09-30 Elemental Altus Royalties Corp. (ELE:CA) is exp...
MacDonald Mines Exploration Ltd. (BMK:CA) is expected to report for quarter end 2023-09-30 ARHT Media Inc. (ART:CA) is expected to report for Q3 2023 Arianne Phosphate Inc. (DAN:CA) is expected to report for quarter end 2023-09-30 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2...
Alvopetro Energy Ltd. (ALV:CA) is expected to report $0.23 for Q3 2023 Martello Technologies Group Inc. (MTLO:CA) is expected to report for quarter end 2023-09-30 George Weston Limited (WN:CA) is expected to report for Q3 2023 EQB Inc. (EQB:CA) is expected to report $2.85 for Q3 2023 ...
News, Short Squeeze, Breakout and More Instantly...
Medexus Pharmaceuticals Inc. Company Name:
MDP:CC Stock Symbol:
TSXC Market:
Medexus Pharmaceuticals Inc. Website:
FDA has Accepted for Review the Treosulfan NDA Management to host conference call at 8:00 AM Eastern time on Wednesday, June 26, 2024 Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and...
Lomiko Metals Inc. (LMR:CA) is expected to report for Q3 2024 Organto Foods Inc. (OGO:CA) is expected to report for Q1 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Blue Horizon Global Capital Corp Com (BHCC:CNX) is expected to report for Q1 2024 Per...
Evertz Technologies Limited (ET:CA) is expected to report $0.22 for Q4 2024 Transat A.T. Inc. Voting and Variable Voting Shares (TRZ:CA) is expected to report $-0.66 for Q2 2024 Medexus Pharmaceuticals Inc. (MDP:CA) is expected to report $-0.03 for Q4 2024 FP Newspapers Inc. (FP:CA) i...